Secondary Dyslipidemia In Obese Children - Is There Evidence For Pharmacological Treatment?

BACKGROUND: Long-term safety, effectiveness and criteria for treatment with statins in children are still unclear in clinical practice. There is very limited evidence for the use of medication to treat children with dyslipidemia secondary to obesity who do not respond well to lifestyle modification....

Descripción completa

Detalles Bibliográficos
Autores principales: Radaelli, Graciane, Sausen, Grasiele, Cesa, Claudia Ciceri, Portal, Vera Lucia, Pellanda, Lucia Campos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Sociedade Brasileira de Cardiologia - SBC 2018
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6173338/
https://www.ncbi.nlm.nih.gov/pubmed/30156604
http://dx.doi.org/10.5935/abc.20180155

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6173338/
https://www.ncbi.nlm.nih.gov/pubmed/30156604
http://dx.doi.org/10.5935/abc.20180155

Ejemplares similares